Published in Obesity and Diabetes Week, March 20th, 2006
According to recent research published in the Canadian Medical Association Journal, "Over the past 30 years, the relation between use of sulfonylureas to treat type 2 diabetes and the risk of cardiovascular events has been vigorously debated. The purpose of this study was to determine if the risk of death changes with level of exposure to sulfonylurea drugs. This was a retrospective, inception cohort study using administrative data from Saskatchewan Health (1991-1999)."
"The 5795 subjects," explained S.H. Simpson and colleagues,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week